Probiotic use and prevalence of candidemia and candiduria in a PICU

Pediatric Critical Care Medicine

Volumn 14, Issue 9, 2013, Pages

  Kumar, Suresh ^a   Singhi, Sunit ^a   Chakrabarti, Arunloke ^a   Bansal, Arun ^a   Jayashree, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Candida; Candidemia; Candiduria; Pediatric intensive care unit; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; PLACEBO; PROBIOTIC AGENT;

ARTICLE; BACTERIUM CULTURE; BED; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BLOOD; BLOODSTREAM INFECTION; CANDIDA; CANDIDEMIA; CANDIDIASIS; CANDIDURIA; CHILD; CONTROLLED STUDY; FEMALE; FUNGUS CULTURE; HUMAN; INTENSIVE CARE UNIT; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS; TEACHING HOSPITAL; URINARY CATHETER; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CANDIDA; CANDIDEMIA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PROBIOTICS; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84892823888     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31829f5d88     Document Type: Article

References (64)

1. Sobel JD, Rex JH: Invasive candidiasis: Turning risk into a practical prevention policy? Clin Infect Dis 2001; 33:187-190
2. Singhi SC, Reddy TC, Chakrabarti A: Candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2004; 5:369-374
3. Neu N, Malik M, Lunding A., et al.: Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Pediatr Infect Dis J 2009; 28:806-809
4. Filioti J, Spiroglou K, Panteliadis C P, et al.: Invasive candidiasis in pedi-atric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med 2007; 33:1272-1283
5. Wisplinghoff H, Bischoff T, Tallent S.M., et al.: Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317
6. Pappas PG, Rex JH, Lee J, et al.; NIAID Mycoses Study Group: A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37:634-643
7. Zaoutis TE, Argon J, Chu J., et al.: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005; 41:1232-1239
8. Richards MJ, Edwards JR, Culver D.H., et al.: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-892
9. Singhi S, Deep A: Invasive candidiasis in pediatric intensive care units. Indian J Pediatr 2009; 76:1033-1044
10. Tortorano AM, Biraghi E, Astolfi A., et al.; FIMUA Candidemia Study Group: European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: Report from one Italian region. J Hosp Infect 2002; 51:297-304
11. Wisplinghoff H, Seifert H, Tallent S.M., et al.: Nosocomial bloodstream infections in pediatric patients in United States hospitals: Epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003; 22:686-691
12. Kicklighter SD, Springer SC, Cox T, et al.: Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107:293-298
13. Kaufman D, Boyle R, Hazen K.C., et al.: Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345:1660-1666
14. Wainer S, Cooper PA, Funk E, et al.: Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatr Infect Dis J 1992; 11:713-716
15. Austin NC, Darlow B: Prophylactic oral antifungal agents to prevent systemic Candida infection in preterm infants. Cochrane Database Syst Rev 2004; 1: CD003478
16. McGuire W, Clerihew L, Austin N: Prophylactic intravenous antifun-gal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2004; 1: CD003850
17. Agarwal R, Sharma N, Chaudhry R., et al.: Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 2003; 36:397-402
18. Millar MR, Bacon C, Smith S.L., et al.: Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993; 69:483-487
19. Wagner RD, Pierson C, Warner T., et al.: Biotherapeutic effects of pro-biotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997; 65:4165-4172
20. Wagner RD, Pierson C, Warner T., et al.: Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albi-cans-colonized immunodeficient mice. J Food Prot 2000; 63:638-644
21. Romeo MG, Romeo DM, Trovato L, et al.: Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: Incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31:63-69
22. Manzoni P, Mostert M, Leonessa M.L., et al.: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin Infect Dis 2006; 42:1735-1742
23. Kumar S, Bansal A, Chakrabarti A., et al.: Evaluation of efficacy of pro-biotics in prevention of Candida colonization in a PICU - A randomized controlled trial. Crit Care Med 2013; 41:565-572
24. Pappu-Katikaneni L.D., Rao KP, Banister E: Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990; 33:20-23
25. Kaufman D, Fairchild KD: Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004; 17:638-680
26. Saiman L, Ludington E, Dawson J.D., et al.; National Epidemiology of Mycoses Study Group: Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20:1119-1124
27. Singhi S, Rao DS, Chakrabarti A: Candida colonization and candi-demia in a pediatric intensive care unit. Pediatr Crit Care Med 2008; 9:91-95
28. Zwolińska-Wcisło M, Brzozowski T, Mach T, et al.: Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006; 57(SUPPL. 9):35-49
29. Jawhara S, Poulain D: Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 2007; 45:691-700
30. Chermesh I, Eliakim R: Probiotics and the gastrointestinal tract: Where are we in 2005? World J Gastroenterol 2006; 12:853-857
31. Suido H, Miyao M: Bifidobacterium longum-fermented broccoli supernatant inhibited the growth of Candida albicans and some pathogenic bacteria in vitro. Biocontrol Sci 2008; 13:41-48
32. Kumar S, Singhi S: Role of probiotics in prevention of Candida infection in critically ill children. Mycoses 2013; 56:204-211
33. Kligler B, Cohrssen A: Probiotics. Am Fam Physician 2008; 78:1073-1078
34. Wilson KH, Perini F: Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56:2610-2614
35. Krasowska A, Murzyn A, Dyjankiewicz A., et al.: The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res 2009; 9:1312-1321
36. Buts J.P., Bernasconi P, Vaerman J.P., et al.: Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 1990; 35:251-256
37. Pothoulakis C, Kelly CP, Joshi M.A., et al.: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104:1108-1115
38. Timmerman HM, Koning CJ, Mulder L, et al.: Monostrain, multistrain and multispecies probiotics - A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96:219-233
39. Dinleyici EC, Dalgic N, Guven S., et al.: The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: Single blinded randomized study. Eur J Pediatr 2013; 172:459-464
40. Johnston BC, Goldenberg JZ, Vandvik P.O., et al.: Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011; 11: CD004827
41. Alberda C, Gramlich L, Meddings J., et al.: Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007; 85:816-823
42. Chapman CM, Gibson GR, Rowland I: Health benefits of probiotics: Are mixtures more effective than single strains? Eur J Nutr 2011; 50:1-17
43. Honeycutt TC, El Khashab M, Wardrop RM III, et al.: Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8:452-458
44. McNaught CE, Woodcock NP, Anderson A.D., et al.: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 2005; 24:211-219
45. Toya S.P., Schraufnagel DE, Tzelepis GE: Candiduria in intensive care units: Association with heavy colonization and candidaemia. J Hosp Infect 2007; 66:201-206
46. Kauffman CA: Candiduria. Clin Infect Dis 2005; 41(SUPPL. 6):S371-S376
47. Chakrabarti A, Reddy TC, Singhi S: Does candiduria predict candi-daemia? Indian J Med Res 1997; 106:513-516
48. Isakow W, Morrow LE, Kollef MH: Probiotics for preventing and treating nosocomial infections: Review of current evidence and recommendations. Chest 2007; 132:286-294
49. Ramirez P, Bassi GL, Torres A: Measures to prevent nosocomial infections during mechanical ventilation. Curr Opin Crit Care 2012; 18:86-92
50. Besselink MG, van Santvoort HC, Buskens E, et al.; Dutch Acute Pancreatitis Study Group: Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-659
51. Rautio M, Jousimies-Somer H, Kauma H., et al.: Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28:1159-1160
52. Cannon JP, Lee TA, Bolanos J.T., et al.: Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005; 24:31-40
53. Horwitch CA, Furseth HA, Larson A.M., et al.: Lactobacillemia in three patients with AIDS. Clin Infect Dis 1995; 21:1460-1462
54. Salminen MK, Rautelin H, Tynkkynen S., et al.: Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004; 38:62-69
55. Mackay AD, Taylor MB, Kibbler C.C., et al.: Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5:290-292
56. Salvana EM, Frank M: Lactobacillus endocarditis: Case report and review of cases reported since 1992. J Infect 2006; 53:e5-e10
57. Sullivan A, Nord CE: Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 2006; 38:327-331
58. Rougé C, Piloquet H, Butel MJ, et al.: Oral supplementation with probi-otics in very-low-birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009; 89:1828-1835
59. Kukkonen K, Savilahti E, Haahtela T., et al.: Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (syn-biotic) treatment: Randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122:8-12
60. Lherm T, Monet C, Nougière B, et al.: Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002; 28:797-801
61. Perapoch J, Planes AM, Querol A, et al.: Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis 2000; 19:468-470
62. Muñoz P., Bouza E, Cuenca-Estrella M, et al.: Saccharomyces cerevi-siae fungemia: An emerging infectious disease. Clin Infect Dis 2005; 40:1625-1634
63. Dinleyici EC, Eren M, Ozen M., et al.: Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012; 12:395-410
64. Laupland KB, Gregson DB, Church D.L., et al.: Invasive Candida species infections: A 5 year population-based assessment. J Antimicrob Chemother 2005; 56:532-537